Meningitis in Children - I.V. Bohadelnikov 2005

Differential diagnosis of purulent meningitis

The etiological Cytology/practical/136.html">Differential Diagnosis OF primary Purulent meningitis, excluding Meningococcal meningitis, often presents major challenges. It is essential to comprehensively evaluate epidemiological data (such as the presence of an infection source, seasonality, contact with an infected person, and the child's age), characteristic clinical manifestations of the disease, and laboratory test results (general clinical, bacteriological, bacterioscopic, and serological). The main differential diagnostic distinctions among primary purulent meningitides are summarized in Table 2.

During the autumn-winter period, the incidence of Influenza and other acute respiratory viral infections (ARVI) accompanied by Central Nervous system (CNS) involvement increases sharply every year. CNS dysfunction manifests in various ways, ranging from lethargy and adynamia to loss of consciousness. Because CNS disorders during influenza and other ARVIs are widespread, physicians' vigilance regarding the potential development of meningitis tends to diminish, which can sometimes lead to diagnostic errors. The differential diagnosis between serous and Purulent meningitis with neurotoxicosis in influenza and other ARVIs is presented in Table 3.

In addition to frequent CNS involvement during widespread outbreaks of influenza and other ARVIs, these conditions are frequently accompanied by hemorrhagic syndrome. Furthermore, improper performance of a lumbar puncture and trauma to the vascular intima can yield Blood-stained CEREBROSPINAL FLUID (CSF). In such cases, CSF analysis not only fails to aid in diagnosis but raises new questions and necessitates a differential diagnosis from intracranial hemorrhages (Table 4).

The diagnosis and differential Diagnosis of Secondary purulent meningitides present significant difficulties. This is because they typically develop against the Background of a severe primary underlying disease accompanied by toxicosis, with simultaneous or sequentially emerging involvement of individual Organs or systems (such as otitis media, enterocolitis, Pneumonia, or Pyelonephritis).

At the initial stage, it is necessary to perform a differential diagnosis between Primary and secondary purulent meningitides. The primary clinical manifestations of primary meningococcal meningitis and secondary purulent meningitides differ substantially, and their differential diagnosis is outlined in Table 5.

The Development of a pathological process in multiple organs simultaneously often masks the manifestations of meningitis, especially in the Early stages of the disease when meningeal and hypertensive syndromes may still be absent. Consequently, the diagnostic value of lumbar puncture increases sharply in secondary purulent meningitides. The indications for this Procedure should be broader the younger the child is, and the longer and more severely they suffer from and unsuccessfully are treated for purulent-septic diseases.

The main differential diagnostic criteria for secondary purulent meningitides are presented in Tables 6 and 7.

In some cases, particularly with the development of purulent meningoencephalitis, it is also necessary to perform a differential diagnosis with conditions such as Brain Tumors and abscesses. The differential diagnosis of meningitis with the aforementioned conditions is presented in Tables 7 and 8.

Table 2

Differential diagnosis of meningococcal meningitis and other primary purulent meningitides

Disease / Signs

Meningococcal meningitis

Pneumococcal meningitis

Haemophilus influenzae meningitis

1

2

3

4

Age

Most commonly in children under 3 years of age;

neonates are rarely affected.

From 1 to 5 years, most commonly children under 3 years of age.

Usually children aged 6 months to 4 years; neonates are rarely affected

Premorbid background

Unchanged

Pneumonia, sinusitis, otitis media, recent ARVI

Debilitated children (Rickets, hypotrophy; frequent ARVI, pneumonia)

Seasonality

Winter-spring

Autumn-winter

Autumn-winter

Onset of the disease

Acute

Subacute in younger children, acute in older children

Usually subacute

Fever intensity and duration

High, 39°–40 °C, lasting 3–7 days

High, 39°–40 °C, lasting 7–25 days

Initially high, 38o–39 °C, then low-grade (subfebrile), lasting up to 4–6 weeks

Meningeal syndrome

Pronounced from the first hours of illness

Pronounced, sometimes incomplete

Moderately pronounced, incomplete, appearing from the 3rd–5th day of illness

Encephalic syndrome

Characteristic of infants in their first year of life

Pronounced, characteristic of 3/4 of patients

May rarely occur in infants in their first year of life

Leading clinical syndrome

Meningeal, infectious-toxic

Infectious-toxic, encephalic

Meningeal, infectious-toxic

Presence of rash

In 70–90% hemorrhagic, stellate, with central necrosis

Not characteristic

Not characteristic

Symptoms of CNS involvement

Impaired consciousness in the first days, seizures. Hearing loss, hemiparesis, ataxia

Impaired consciousness, focal seizures, paralysis, cranial nerve palsies. Hydrocephalus

Occasionally cranial nerve involvement, limb paresis

Course

Acute, rarely protracted

Acute in older children, protracted in younger children

Wavy (relapsing). Tendency toward CSF pathway block

Possible somatic disorders

Arthritis, pneumonia

Pneumonia, otitis media, sinusitis

Tracheitis, Bronchitis, rhinitis

Blood test

Leukocytosis, neutrophilia with a left shift, elevated ESR

Leukocytosis, neutrophilia with a left shift, elevated ESR

Anemia, leukocytosis, neutrophilia, rarely elevated ESR

CSF

Turbid, whitish; pleocytosis ranging from hundreds to thousands per 1 µL, predominantly neutrophilic; elevated protein, decreased glucose

Turbid, greenish; pleocytosis 300–1500 per 1 µL, predominantly neutrophilic;

elevated protein level

Turbid, greenish; pleocytosis 300–900 per 1 µL, predominantly neutrophilic; elevated protein level

Source material for pathogen isolation

Blood, CSF, urine, nasopharyngeal mucus

CSF, content from purulent foci

CSF, blood, mucus, sputum, content from purulent foci

Bacterioscopic examination

Intracellularly located Gram-negative diplococci

Intra- and extracellularly located Gram-positive diplococci in pairs

Polymorphic coccobacilli forming short and long threads, occasionally micrococci in pairs

Table 3

Differential diagnosis of serous and purulent meningitides with neurotoxicosis in influenza and other ARVIs

Disease

Sign

Viral serous meningitis

Neurotoxicosis in influenza and other ARVI

Meningococcal meningitis

1

2

3

4

Epidemiological history

Contact with an infected person, more often in rural areas

Contact with a patient with ARVI

Contact with a patient or meningococcal carrier

Age

Any

Any

Any, but predominantly children under 3 years of age

Incidence

Sporadic,

epidemic

Sporadic, epidemic

Sporadic

Seasonality

Autumn-winter-spring

Autumn-winter

Winter-spring

Transmission routes

Airborne, alimentary, rarely contact

Exclusively airborne

Airborne

Onset of the disease

Acute

Acute

Acute (onset can often be timed to the exact hour)

Fever intensity

38°–39 °C, may be biphasic

Often above 400 °C

39°–40 °C and higher

Catarrhal manifestations

May be present

Pronounced significantly

May be present

Oropharyngeal mucosal changes

Not characteristic

Hyperemia, edema, petechial hemorrhages, granularity of the posterior pharyngeal wall

May resemble changes seen in ARVI

Skin rash

Not characteristic

Fine-spotted hemorrhagic rash on the skin and mucous membranes

Hemorrhagic stellate rash with central necrosis

Vomiting

In the acute period, recurrent

Only at the peak of toxicosis

Recurrent, multiple

Headache

Severe, but not prolonged

Severe, but not prolonged

Pronounced, intense, diffuse or localized in the frontotemporal regions

Consciousness

Agitation or depression of consciousness may occur, up to loss of consciousness

Impaired, ranging from somnolence to complete loss of consciousness

Impaired, ranging from somnolence to complete loss of consciousness

Seizures

At the peak of toxicosis

At the peak of fever, brief tonic-clonic

Generalized tonic-clonic

Predominant syndrome

Intracranial Hypertension

General infectious

General infectious, meningeal,

hypertensive

Meningeal syndrome

Moderately pronounced, dissociated

Inconstant and incomplete

Pronounced from the first hours

Encephalic syndrome

Not characteristic

May be present

Clonus of the feet, muscular hypotonia, cranial nerve palsies

Severity of general condition

Mostly moderate, less frequently severe

From mild to extremely severe

Severe or extremely severe

Peripheral blood

Leukopenia, slight

neutrophilia with a left shift of the formula, normal ESR

On the first day – leukocytosis; on days 2–3 – leukopenia, eosinophilia, lymphocytosis, normal ESR

Leukocytosis, eosinophilia, band neutrophil shift to the left, elevated ESR

CSF

CSF pressure is elevated; fluid is clear and colorless; pleocytosis initially mixed, then predominantly lymphocytic, ranging from tens to hundreds per 1 µL; protein, glucose, and chloride levels within normal limits

CSF pressure significantly elevated; clear, whitish fluid; slight lymphocytic pleocytosis; moderately elevated protein level; glucose and chloride levels normal

CSF pressure elevated; fluid is turbid, milky or yellowish-green; neutrophilic pleocytosis ranging from hundreds to thousands per 1 µL; protein level elevated to 1–4.5 g/L; glucose and chloride levels decreased

Table 4

Differential diagnosis of viral meningitis and intracranial hemorrhages

Disease/Signs

Viral meningitis

Subarachnoid

Hemorrhage

Subdural hemorrhage or effusion

Epidural hemorrhage

1

2

3

4

5

Age

Any

Early childhood and school age

Any

More often older school age

Etiology

Viruses (enteroviruses, influenza virus)

Vascular malformations (angiomas, arteriovenous aneurysms)

Birth trauma, Skull trauma, previous bacterial meningitis

Skull trauma with bone fracture

Onset of the disease

Acute

Sudden, with progressive signs of impaired consciousness

Gradual,

slow

Gradual

Temperature reaction

38°–39 °C for 2–5 days

Sometimes subfebrile

Absent

Absent

Meningeal syndrome

Moderate or pronounced in the first days, sometimes dissociated

Pronounced

Clearly pronounced

Not characteristic

Leading CNS syndrome

Intracranial

hypertension

Impaired consciousness,

meningeal signs

Progressive increase in intracranial pressure

Progressive increase in intracranial pressure

Other symptoms

Catarrhal signs,

intestinal disorders,

epidemic parotitis signs, etc.

Vascular bruit over skull bones, tense pulse, elevated blood pressure

Refusal to feed

Signs of brain herniation

Headache

Severe, but not prolonged

Sudden, excruciating pain in the occipital region

Severe, recurring, localized in the occipital region

Severe, persistent, diffuse

Vomiting

Recurrent


Recurrent

May be present

Other CNS symptoms

Focal symptoms,

transient cranial

nerve involvement

Motor disorders (hemiplegia, seizures), cranial nerve involvement

Epileptic seizures

(partial, secondary –

generalized), progressive

hemiparesis, hemianesthesia,

gaze palsy, anisocoria.

Hemiparesis on the side

opposite to the trauma,

clonic seizures on the side

opposite to the hematoma,

homolateral mydriasis

CSF

No blood admixtures,

clear, opalescent,

pleocytosis within

0.1–0.2×109/L, lymphocytic in nature

Uniformly bloody, xanthochromic, erythrocytes have a thornapple shape

No blood admixtures, absence of inflammatory signs

No blood admixtures, absence of inflammatory signs

Fundus oculi

Unchanged

Hemorrhages

Papilledema

Papilledema

Other CNS symptoms

Focal symptoms,

transient cranial

nerve involvement

Motor disorders (hemiplegia, seizures), cranial nerve involvement

Epileptic seizures

(partial, secondary –

generalized),

progressive hemiparesis,

hemianesthesia, gaze palsy,

anisocoria.

Hemiparesis on the side

opposite to the trauma,

clonic seizures on the side

opposite to the hematoma,

homolateral mydriasis

CSF

No blood admixtures,

clear, opalescent,

pleocytosis within

0.1–0.2×109/L,

lymphocytic

in nature

Uniformly bloody, xanthochromic, erythrocytes have a thornapple shape

No blood admixtures, absence of inflammatory signs

No blood admixtures, absence of

inflammatory signs

Fundus oculi

Unchanged

Hemorrhages

Papilledema

Papilledema



Last update: 08/08/2026

Editorial and Educational Adaptation: This material has been compiled based on the primary/original source text. The project team performed an editorial review, corrected technical inaccuracies, structured sections, and adapted the content for an educational format.

What was processed:

  • elimination of formatting defects (OCR errors, structural breaks, corrupted characters);
  • editorial organization of content;
  • standardization of terminology in accordance with academic sources;
  • verification of factual statements against the original source text.

All mentions of the author, publication year, and origin of the primary text have been preserved in accordance with the source.